» Articles » PMID: 21531882

Thrombocytopenia in Staphylococcus Aureus Bacteremia: Risk Factors and Prognostic Importance

Overview
Journal Mayo Clin Proc
Specialty General Medicine
Date 2011 May 3
PMID 21531882
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To identify risk factors and outcomes associated with thrombocytopenia at sepsis onset in Staphylococcus aureus bacteremia.

Patients And Methods: This single-center, retrospective, cohort study consists of all adult patients with a first episode of clinical S aureus bacteremia between April 1, 1988, and September 30, 1994, and between January 1, 1999, and December 31, 2007. Thrombocytopenia was defined as a platelet count less than 150 × 10(9)/L. The primary outcome was 30-day all-cause mortality. Risk factors for 30-day all-cause mortality were identified using univariate and multivariable analyses. Multivariable analysis was conducted using forward step logistic regression analysis. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated for risk of death.

Results: A total of 1052 patients had clinical S aureus bacteremia. Thrombocytopenia at sepsis onset was present in 235 patients (22.3%). Thrombocytopenia was associated with community-acquired bacteremia, infections caused by methicillin-sensitive S aureus, high-magnitude bacteremia (defined as >4 positive blood cultures [≥ 3 separate positive blood culture sets]), and endocarditis. Patients with thrombocytopenia presented more commonly with severe sepsis reflected by septic shock and acute renal failure. Thirty-day mortality was significantly higher among patients with thrombocytopenia (132/235 [56.2%]) vs those without thrombocytopenia (281/817 [34.4%]; P<.001). Higher mortality was associated with the degree of thrombocytopenia. In multivariable analysis, thrombocytopenia at baseline remained an independent risk factor for 30-day mortality (OR, 2.82; 95% CI, 1.87-4.24). The adjusted association between thrombocytopenia and death remained similar among the 917 patients with monomicrobial bacteremia (OR, 2.88; 95% CI, 1.83-4.53) and the 945 patients who did not die within the first 48 hours (OR, 2.88; 95% CI, 1.87-4.45.).

Conclusion: We observed a strong association between thrombocytopenia at sepsis onset and all-cause mortality in S aureus bacteremia, possibly related to mechanisms other than sepsis alone.

Citing Articles

Iloprost Concentration-Dependently Attenuates Platelet Function and Apoptosis by Elevating PKA Activity.

Wang X, Chen S, Wan J, Liu C, Yan Y, Khan M J Cell Mol Med. 2025; 29(3):e70403.

PMID: 39929746 PMC: 11810529. DOI: 10.1111/jcmm.70403.


Determining the Prognostic Value of Complete Blood Count Subgroup Parameters in Bacteremia.

Matthews E, Dilworth T J Patient Cent Res Rev. 2024; 11(3):197-203.

PMID: 39439536 PMC: 11493308. DOI: 10.17294/2330-0698.2073.


Prognostic factors and clinical outcomes in Fournier's Gangrene: a retrospective study of 35 patients.

Hong H, Lee J, Park C BMC Infect Dis. 2024; 24(1):958.

PMID: 39261759 PMC: 11391849. DOI: 10.1186/s12879-024-09900-1.


Linezolid-Associated Thrombocytopenia: Assessment of Risk Factors in Patients without Hemato-Oncologic Diseases.

Thabit A, Alghamdi A, Alsaeed A, Magbool N, Alsowaida Y, Mahrous A J Clin Med. 2024; 13(8).

PMID: 38673653 PMC: 11050941. DOI: 10.3390/jcm13082380.


Mortality patterns in patients with Staphylococcus aureus bacteremia during the COVID-19 pandemic: Predictors and insights.

Abdollahi A, Nojomi M, Karimi Y, Ranjbar M Heliyon. 2024; 10(2):e24511.

PMID: 38312595 PMC: 10835178. DOI: 10.1016/j.heliyon.2024.e24511.


References
1.
Willcox P, Rayner B, Whitelaw D . Community-acquired Staphylococcus aureus bacteraemia in patients who do not abuse intravenous drugs. QJM. 1998; 91(1):41-7. DOI: 10.1093/qjmed/91.1.41. View

2.
Friedman N, Kaye K, Stout J, McGarry S, Trivette S, Briggs J . Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002; 137(10):791-7. DOI: 10.7326/0003-4819-137-10-200211190-00007. View

3.
Leibovici L, Gransden W, Eykyn S, Konsiberger H, Drucker M, Pitlik S . Clinical index to predict bacteraemia caused by staphylococci. J Intern Med. 1993; 234(1):83-9. DOI: 10.1111/j.1365-2796.1993.tb00709.x. View

4.
Manohar M, Maheswaran S, FROMMES S, Lindorfer R . Platelet damaging factor, a fifth activity of staphylococcal alpha-toxin. J Bacteriol. 1967; 94(1):224-31. PMC: 251893. DOI: 10.1128/jb.94.1.224-231.1967. View

5.
Malani P, Rana M, Banerjee M, Bradley S . Staphylococcus aureus bloodstream infections: the association between age and mortality and functional status. J Am Geriatr Soc. 2008; 56(8):1485-9. DOI: 10.1111/j.1532-5415.2008.01823.x. View